Assal, Amer

Publications

Sort by

Co-Author Network

selected publications

The prospect of universal coronavirus immunity: characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. Frontiers in immunology. 2023 Academic Article GET IT
Times cited: 3
Evaluation of a Protocol for Reducing Venous Thromboembolism in Hematopoietic Stem Cell Transplant Recipients. Journal of pharmacy practice. 2023 Letter GET IT
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis. Haematologica. 2023 Academic Article GET IT
Times cited: 17
Improved serologic responses to DTaP over Tdap vaccination in adult hematopoietic cell transplant recipients. European journal of haematology. 2023 Academic Article GET IT
The prospect of universal coronavirus immunity: a characterization of reciprocal and non-reciprocal T cell responses against SARS-CoV2 and common human coronaviruses. 2023 GET IT
Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 2
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. 2022 GET IT
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances. 2022 Academic Article GET IT
Times cited: 9
Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation. Transplantation and cellular therapy. 2021 Academic Article GET IT
Times cited: 11
Number of HLA-Mismatched Eplets Is Not Associated with Major Outcomes in Haploidentical Transplantation with Post-Transplantation Cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study. Transplantation and cellular therapy. 2021 Academic Article GET IT
Times cited: 6
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis. Bone marrow transplantation. 2021 Academic Article GET IT
Times cited: 5
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis. Bone marrow transplantation. 2021 Academic Article GET IT
Times cited: 14
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome. Blood advances. 2021 Academic Article GET IT
Times cited: 29
Janus Kinase Inhibitors and Cell Therapy. Frontiers in immunology. 2021 Review GET IT
Times cited: 5
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults. Transplantation and cellular therapy. 2021 Academic Article GET IT
Times cited: 20
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. 2021 GET IT
Times cited: 2
Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. 2021 GET IT
Times cited: 1
Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. 2021 GET IT
Development of T-cell immunity in a liver and hematopoietic stem cell transplant recipient following coronavirus disease 2019 infection. 2021 GET IT
Times cited: 2
Asymmetric optic disc edema in a young patient with POEMS: A rare presentation of a rare disease. 2021 GET IT
Times cited: 1
Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies. Annals of hematology. 2021 Academic Article GET IT
Times cited: 12
Extended letermovir administration, beyond day 100, is effective for CMV prophylaxis in patients with graft versus host disease. Transplant infectious disease : an official journal of the Transplantation Society. 2020 Academic Article GET IT
Times cited: 14
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma. British journal of haematology. 2020 Academic Article GET IT
Times cited: 7
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood advances. 2020 Academic Article GET IT
Times cited: 18
Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era. Leukemia. 2020 Academic Article GET IT
Times cited: 31
Rewriting the rules for care of MDS and AML patients in the time of COVID-19. Leukemia research reports. 2020 Academic Article GET IT
Times cited: 15
Case Report: Carfilzomib-induced Thrombotic Microangiopathy With Complement Activation Treated Successfully With Eculizumab. 2020 GET IT
Times cited: 14
Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma. Blood cancer journal. 2020 Letter GET IT
Times cited: 6
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study. Journal of the American Society of Nephrology : JASN. 2020 Academic Article GET IT
Times cited: 273
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. 2019 Academic Article GET IT
Times cited: 22
HIV portends a poor prognosis in myelodysplastic syndromes. Leukemia & lymphoma. 2019 Academic Article GET IT
Times cited: 4
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood advances. 2019 Academic Article GET IT
Times cited: 98
Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 19
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia. Blood advances. 2018 Academic Article GET IT
Times cited: 33
Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 12
Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 76
Risk factors and prognosis of ovarian vein thrombosis. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 2017 Academic Article GET IT
Times cited: 6
Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy. Oncotarget. 2016 Academic Article GET IT
Times cited: 31
Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia. Cancer research. 2016 Academic Article GET IT
Times cited: 36
Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor. Leukemia & lymphoma. 2016 Letter GET IT
Times cited: 1
Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report. American journal of hematology. 2016 Article GET IT
Times cited: 7
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1. Immunotherapy. 2015 Review GET IT
Times cited: 44
Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway. Trends in molecular medicine. 2014 Review GET IT
Times cited: 651

more ...

less ...

Background

education and training

M.D., New York University School of Medicine 2008
B.A., City College, City University of New York 2004

Contact

full name

Amer Assal

primary email

ama9078@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Amer Assal Associate Professor of Medicine (Pending Appointment at Rank)

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage